"Clinically predictive preclinical efficacy testing services at your disposal"

Jussi Halleen - CEO, Pharmatest Services


Chief Executive Officer,
Jussi Halleen PhD, Adjunct Professor

Dr. Halleen is one of the founders of Pharmatest and he has been the CEO since 1999. Before joining Pharmatest he was active in academic bone research at the Universities of Oulu and Turku, where he prepared his thesis on the role of tartrate-resistant acid phosphatase (TRACP) in osteoclastic bone resorption and as a biochemical marker of bone turnover. His responsibilities in Pharmatest include the company’s Sales and Customer Management Process and its development.



Chief Operating Officer,
Jenni Bernoulli PhD

Dr. Bernoulli joined Pharmatest through the merger of Orthotopix Ltd at the end of 2009. Before joining Orthotopix she was active in academic research at the University of Turku, Finland. An experimental model of prostatic diseases that she developed and studied in her doctoral thesis established to become an optimized and validated service product of Pharmatest. Her primary responsibilities in Pharmatest include human resources management and controlling daily operations at the company's headquarters and preclinical research facilities. Her responsibilities include the company’s Production Process and R&D process and their development.